2225109-03-3
2225109-03-3
Chemical Structure
Tafolecimab
Synonym(s): IBI-306
- CAS No.: 2225109-03-3
- Formula:N/A
- Molecular Weight:(145.34 kDa)
IUPAC Name: 4-nitrobenzen-2,3,5,6-d4-amine
SMILES: [Tafolecimab]
Biological Activity: Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tafolecimab | 95.04% | Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
